Click for best price
Endometrial Cancer Treatment Market Size, Share 2024
| Market size in 2023 |
US$ 22200 million
|
Forecast Market size by 2029 |
US$ 29080 million
|
| Growth Rate |
CAGR of 3.9% |
Number of Pages |
61 Pages |
This report aims to provide a comprehensive presentation of the global market for Endometrial Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endometrial Cancer Treatment. This report contains market size and forecasts of Endometrial Cancer Treatment in global, including the following market information:
Global Endometrial Cancer Treatment Market Revenue, 2019-2024, 2024-2029, ($ millions)
Global top five companies in 2023 (%)
The global Endometrial Cancer Treatment market was valued at US$ 22200 million in 2023 and is projected to reach US$ 29080 million by 2029, at a CAGR of 3.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Chemotherapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Endometrial Cancer Treatment include Ariad, Abbott, BD, GlaxoSmithKline, Merck, Novartis, Sanofi, Siemens and Roche, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Endometrial Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Endometrial Cancer Treatment Market, by Type, 2019-2024, 2024-2029 ($ millions)
Global Endometrial Cancer Treatment Market Segment Percentages, by Type, 2023 (%)
Chemotherapy
Surgical
Global Endometrial Cancer Treatment Market, by Application, 2019-2024, 2024-2029 ($ millions)
Global Endometrial Cancer Treatment Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Global Endometrial Cancer Treatment Market, By Region and Country, 2019-2024, 2024-2029 ($ Millions)
Global Endometrial Cancer Treatment Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Endometrial Cancer Treatment revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Endometrial Cancer Treatment revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ariad
Abbott
BD
GlaxoSmithKline
Merck
Novartis
Sanofi
Siemens
Roche
Outline of Major Chapters:
Chapter 1: Introduces the definition of Endometrial Cancer Treatment, market overview.
Chapter 2: Global Endometrial Cancer Treatment market size in revenue.
Chapter 3: Detailed analysis of Endometrial Cancer Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Endometrial Cancer Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Endometrial Cancer Treatment Market, Global Outlook and Forecast 2024-2031 |
| Market size in 2023 |
US$ 22200 million
|
| Forecast Market size by 2029 |
US$ 29080 million
|
| Growth Rate |
CAGR of 3.9% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Endometrial Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Endometrial Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Endometrial Cancer Treatment Overall Market Size
2.1 Global Endometrial Cancer Treatment Market Size: 2022 VS 2031
2.2 Global Endometrial Cancer Treatment Market Size, Prospects & Forecasts: 2019-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Endometrial Cancer Treatment Players in Global Market
3.2 Top Global Endometrial Cancer Treatment Companies Ranked by Revenue
3.3 Global Endometrial Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Endometrial Cancer Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Endometrial Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Endometrial Cancer Treatment Players in Global Market
3.6.1 List of Global Tier 1 Endometrial Cancer Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Endometrial Cancer Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Endometrial Cancer Treatment Market Size Markets, 2022 & 2031
4.1.2 Chemotherapy
4.1.3 Surgical
4.2 By Type - Global Endometrial Cancer Treatment Revenue & Forecasts
4.2.1 By Type - Global Endometrial Cancer Treatment Revenue, 2019-2024
4.2.2 By Type - Global Endometrial Cancer Treatment Revenue, 2024-2031
4.2.3 By Type - Global Endometrial Cancer Treatment Revenue Market Share, 2019-2031
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Endometrial Cancer Treatment Market Size, 2022 & 2031
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Endometrial Cancer Treatment Revenue & Forecasts
5.2.1 By Application - Global Endometrial Cancer Treatment Revenue, 2019-2024
5.2.2 By Application - Global Endometrial Cancer Treatment Revenue, 2024-2031
5.2.3 By Application - Global Endometrial Cancer Treatment Revenue Market Share, 2019-2031
6 Sights by Region
6.1 By Region - Global Endometrial Cancer Treatment Market Size, 2022 & 2031
6.2 By Region - Global Endometrial Cancer Treatment Revenue & Forecasts
6.2.1 By Region - Global Endometrial Cancer Treatment Revenue, 2019-2024
6.2.2 By Region - Global Endometrial Cancer Treatment Revenue, 2024-2031
6.2.3 By Region - Global Endometrial Cancer Treatment Revenue Market Share, 2019-2031
6.3 North America
6.3.1 By Country - North America Endometrial Cancer Treatment Revenue, 2019-2031
6.3.2 US Endometrial Cancer Treatment Market Size, 2019-2031
6.3.3 Canada Endometrial Cancer Treatment Market Size, 2019-2031
6.3.4 Mexico Endometrial Cancer Treatment Market Size, 2019-2031
6.4 Europe
6.4.1 By Country - Europe Endometrial Cancer Treatment Revenue, 2019-2031
6.4.2 Germany Endometrial Cancer Treatment Market Size, 2019-2031
6.4.3 France Endometrial Cancer Treatment Market Size, 2019-2031
6.4.4 U.K. Endometrial Cancer Treatment Market Size, 2019-2031
6.4.5 Italy Endometrial Cancer Treatment Market Size, 2019-2031
6.4.6 Russia Endometrial Cancer Treatment Market Size, 2019-2031
6.4.7 Nordic Countries Endometrial Cancer Treatment Market Size, 2019-2031
6.4.8 Benelux Endometrial Cancer Treatment Market Size, 2019-2031
6.5 Asia
6.5.1 By Region - Asia Endometrial Cancer Treatment Revenue, 2019-2031
6.5.2 China Endometrial Cancer Treatment Market Size, 2019-2031
6.5.3 Japan Endometrial Cancer Treatment Market Size, 2019-2031
6.5.4 South Korea Endometrial Cancer Treatment Market Size, 2019-2031
6.5.5 Southeast Asia Endometrial Cancer Treatment Market Size, 2019-2031
6.5.6 India Endometrial Cancer Treatment Market Size, 2019-2031
6.6 South America
6.6.1 By Country - South America Endometrial Cancer Treatment Revenue, 2019-2031
6.6.2 Brazil Endometrial Cancer Treatment Market Size, 2019-2031
6.6.3 Argentina Endometrial Cancer Treatment Market Size, 2019-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Endometrial Cancer Treatment Revenue, 2019-2031
6.7.2 Turkey Endometrial Cancer Treatment Market Size, 2019-2031
6.7.3 Israel Endometrial Cancer Treatment Market Size, 2019-2031
6.7.4 Saudi Arabia Endometrial Cancer Treatment Market Size, 2019-2031
6.7.5 UAE Endometrial Cancer Treatment Market Size, 2019-2031
7 Endometrial Cancer Treatment Companies Profiles
7.1 Ariad
7.1.1 Ariad Company Summary
7.1.2 Ariad Business Overview
7.1.3 Ariad Endometrial Cancer Treatment Major Product Offerings
7.1.4 Ariad Endometrial Cancer Treatment Revenue in Global Market (2019-2024)
7.1.5 Ariad Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Endometrial Cancer Treatment Major Product Offerings
7.2.4 Abbott Endometrial Cancer Treatment Revenue in Global Market (2019-2024)
7.2.5 Abbott Key News & Latest Developments
7.3 BD
7.3.1 BD Company Summary
7.3.2 BD Business Overview
7.3.3 BD Endometrial Cancer Treatment Major Product Offerings
7.3.4 BD Endometrial Cancer Treatment Revenue in Global Market (2019-2024)
7.3.5 BD Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Endometrial Cancer Treatment Major Product Offerings
7.4.4 GlaxoSmithKline Endometrial Cancer Treatment Revenue in Global Market (2019-2024)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Endometrial Cancer Treatment Major Product Offerings
7.5.4 Merck Endometrial Cancer Treatment Revenue in Global Market (2019-2024)
7.5.5 Merck Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Endometrial Cancer Treatment Major Product Offerings
7.6.4 Novartis Endometrial Cancer Treatment Revenue in Global Market (2019-2024)
7.6.5 Novartis Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Endometrial Cancer Treatment Major Product Offerings
7.7.4 Sanofi Endometrial Cancer Treatment Revenue in Global Market (2019-2024)
7.7.5 Sanofi Key News & Latest Developments
7.8 Siemens
7.8.1 Siemens Company Summary
7.8.2 Siemens Business Overview
7.8.3 Siemens Endometrial Cancer Treatment Major Product Offerings
7.8.4 Siemens Endometrial Cancer Treatment Revenue in Global Market (2019-2024)
7.8.5 Siemens Key News & Latest Developments
7.9 Roche
7.9.1 Roche Company Summary
7.9.2 Roche Business Overview
7.9.3 Roche Endometrial Cancer Treatment Major Product Offerings
7.9.4 Roche Endometrial Cancer Treatment Revenue in Global Market (2019-2024)
7.9.5 Roche Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Endometrial Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Endometrial Cancer Treatment Market Drivers in Global Market
Table 3. Endometrial Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Endometrial Cancer Treatment in Global Market
Table 5. Top Endometrial Cancer Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Endometrial Cancer Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Endometrial Cancer Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Endometrial Cancer Treatment Product Type
Table 9. List of Global Tier 1 Endometrial Cancer Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Endometrial Cancer Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Endometrial Cancer Treatment Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Endometrial Cancer Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Endometrial Cancer Treatment Revenue in Global (US$, Mn), 2024-2031
Table 14. By Application ? Global Endometrial Cancer Treatment Revenue, (US$, Mn), 2022 & 2031
Table 15. By Application - Endometrial Cancer Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Endometrial Cancer Treatment Revenue in Global (US$, Mn), 2024-2031
Table 17. By Region ? Global Endometrial Cancer Treatment Revenue, (US$, Mn), 2022 & 2031
Table 18. By Region - Global Endometrial Cancer Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Endometrial Cancer Treatment Revenue (US$, Mn), 2024-2031
Table 20. By Country - North America Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Endometrial Cancer Treatment Revenue, (US$, Mn), 2024-2031
Table 22. By Country - Europe Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Endometrial Cancer Treatment Revenue, (US$, Mn), 2024-2031
Table 24. By Region - Asia Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Endometrial Cancer Treatment Revenue, (US$, Mn), 2024-2031
Table 26. By Country - South America Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Endometrial Cancer Treatment Revenue, (US$, Mn), 2024-2031
Table 28. By Country - Middle East & Africa Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Endometrial Cancer Treatment Revenue, (US$, Mn), 2024-2031
Table 30. Ariad Company Summary
Table 31. Ariad Endometrial Cancer Treatment Product Offerings
Table 32. Ariad Endometrial Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. Ariad Key News & Latest Developments
Table 34. Abbott Company Summary
Table 35. Abbott Endometrial Cancer Treatment Product Offerings
Table 36. Abbott Endometrial Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. Abbott Key News & Latest Developments
Table 38. BD Company Summary
Table 39. BD Endometrial Cancer Treatment Product Offerings
Table 40. BD Endometrial Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. BD Key News & Latest Developments
Table 42. GlaxoSmithKline Company Summary
Table 43. GlaxoSmithKline Endometrial Cancer Treatment Product Offerings
Table 44. GlaxoSmithKline Endometrial Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. GlaxoSmithKline Key News & Latest Developments
Table 46. Merck Company Summary
Table 47. Merck Endometrial Cancer Treatment Product Offerings
Table 48. Merck Endometrial Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. Merck Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Endometrial Cancer Treatment Product Offerings
Table 52. Novartis Endometrial Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. Novartis Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Endometrial Cancer Treatment Product Offerings
Table 56. Sanofi Endometrial Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. Sanofi Key News & Latest Developments
Table 58. Siemens Company Summary
Table 59. Siemens Endometrial Cancer Treatment Product Offerings
Table 60. Siemens Endometrial Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 61. Siemens Key News & Latest Developments
Table 62. Roche Company Summary
Table 63. Roche Endometrial Cancer Treatment Product Offerings
Table 64. Roche Endometrial Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 65. Roche Key News & Latest Developments
List of Figures
Figure 1. Endometrial Cancer Treatment Segment by Type in 2022
Figure 2. Endometrial Cancer Treatment Segment by Application in 2022
Figure 3. Global Endometrial Cancer Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Endometrial Cancer Treatment Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global Endometrial Cancer Treatment Revenue, 2019-2031 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Endometrial Cancer Treatment Revenue in 2022
Figure 8. By Type - Global Endometrial Cancer Treatment Revenue Market Share, 2019-2031
Figure 9. By Application - Global Endometrial Cancer Treatment Revenue Market Share, 2019-2031
Figure 10. By Type - Global Endometrial Cancer Treatment Revenue, (US$, Mn), 2022 & 2031
Figure 11. By Type - Global Endometrial Cancer Treatment Revenue Market Share, 2019-2031
Figure 12. By Application - Global Endometrial Cancer Treatment Revenue, (US$, Mn), 2022 & 2031
Figure 13. By Application - Global Endometrial Cancer Treatment Revenue Market Share, 2019-2031
Figure 14. By Region - Global Endometrial Cancer Treatment Revenue Market Share, 2019-2031
Figure 15. By Country - North America Endometrial Cancer Treatment Revenue Market Share, 2019-2031
Figure 16. US Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 17. Canada Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 18. Mexico Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 19. By Country - Europe Endometrial Cancer Treatment Revenue Market Share, 2019-2031
Figure 20. Germany Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 21. France Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 22. U.K. Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 23. Italy Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 24. Russia Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 25. Nordic Countries Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 26. Benelux Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 27. By Region - Asia Endometrial Cancer Treatment Revenue Market Share, 2019-2031
Figure 28. China Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 29. Japan Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 30. South Korea Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 31. Southeast Asia Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 32. India Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 33. By Country - South America Endometrial Cancer Treatment Revenue Market Share, 2019-2031
Figure 34. Brazil Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 35. Argentina Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 36. By Country - Middle East & Africa Endometrial Cancer Treatment Revenue Market Share, 2019-2031
Figure 37. Turkey Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 38. Israel Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 39. Saudi Arabia Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 40. UAE Endometrial Cancer Treatment Revenue, (US$, Mn), 2019-2031
Figure 41. Ariad Endometrial Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Abbott Endometrial Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. BD Endometrial Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. GlaxoSmithKline Endometrial Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Merck Endometrial Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Novartis Endometrial Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Sanofi Endometrial Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Siemens Endometrial Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Roche Endometrial Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
